NL-OMON30088已完成不适用
Impact of Immune Responses in Chronic Hepatitis C Genotype 1 Virus Infected Patients during Treatment with Peg-Interferon-alpha-2b and Ribavirin. - CIRES = hCv Immune RESponses
Foundation for Liver Research (SLO)0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational invasive
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Male and female patients between 18-70 years of age, with evidence of a chronic hepatitis C Genotype 1 infection.
- •-No previous treatment with, peginterferon or conventional interferon plus ribavirin combination therapy.
- •-Indication for antiviral therapy of hepatitis C according to current clinical guidelines.
- •-Written informed consent.
排除标准
- •History or other evidence of severe illness, malignancy or any other condition which would make the patient, in the opinion of the investigator, unsuitable for the study.
- •Presence of contra-indications for antiviral therapy with interferon or antiviral therapy.
研究者
相似试验
进行中（未招募）
1 期
Hepatitis C virusdynamik og immunaktivering hos HCV/HIV-koinficerede patienter under behandling med pegyleret interferon a-2a og ribavirin - DICO-DHIV-infection and concomittant HCV-infectionEUCTR2005-002202-28-DKRigshospitalet20
招募中
不适用
Immune phenotyping in chronic hepatitis C patients treated with Sofosbuvir and Daclatasvir combination with or without Ribavirin for 12 or 24 weeks -SODA studyNL-OMON27532AMC32
进行中（未招募）
1 期
A study looking at the immune response in chronic hepatitis C patients treated with Sofosbuvir and Daclatasvir combination with or without Ribavirin for 12 or 24 weeks.Chronic hepatitis CEUCTR2014-002808-25-NLAcademic Medical Center Amsterdam
已完成
3 期
Immune phenotyping in chronic HCV patients treated with Sofosbuvir and Daclatasvir combination for 12 or 24 weeks * SODA studyChronic hepatitis C1001965410047438Hepatitis CNL-OMON44573Academisch Medisch Centrum32
尚未招募
不适用
Characterization of immune responses in Hepatitis B patients experiencing a flare after stopping nucleot(s)ide analogue therapycHBVChronic hepatitis B1001965410047438NL-OMON50840Stichting Leveronderzoek50